검색결과 : 40건
| No. | Article |
|---|---|
| 1 |
Variant-proof vaccines - invest now for the next pandemic Burton DR, Topol EJ Nature, 590(7846), 386, 2021 |
| 2 |
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody Rappazzo CG, Tse LV, Kaku CI, Wrapp D, Sakharkar M, Huang DL, Deveau LM, Yockachonis TJ, Herbert AS, Battles MB, O'Brien CM, Brown ME, Geoghegan JC, Belk J, Peng LH, Yang LL, Hou YX, Scobey TD, Burton DR, Nemazee D, Dye JM, Voss JE, Gunn BM, McLellan JS, Baric RS, Gralinski LE, Walker LM Science, 371(6531), 823, 2021 |
| 3 |
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model Rogers TF, Zhao FZ, Huang DL, Beutler N, Burns A, He WT, Limbo O, Smith C, Song G, Woehl J, Yang LL, Abbott RK, Callaghan S, Garcia E, Hurtado J, Parren M, Peng LH, Ramirez S, Ricketts J, Ricciardi MJ, Rawlings SA, Wu NC, Yuan M, Smith DM, Nemazee D, Teijaro JR, Voss JE, Wilson IA, Andrabi R, Briney B, Landais E, Sok D, Jardine JG, Burton DR Science, 369(6506), 956, 2020 |
| 4 |
Broad neutralization of SARS-related viruses by human monoclonal antibodies Wec AZ, Wrapp D, Herbert AS, Maurer DP, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang DL, Tse LV, Johnson NV, Hsieh CL, Wang NS, Nett JH, Champney E, Burnina I, Brown M, Lin S, Sinclair M, Johnson C, Pudi S, Bortz R, Wirchnianski AS, Laudermilch E, Florez C, Fels JM, O'Brien CM, Graham BS, Nemazee D, Burton DR, Baric RS, Voss JE, Chandran K, Dye JM, McLellan JS, Walker LM Science, 369(6504), 731, 2020 |
| 5 |
Structural basis of a shared antibody response to SARS-CoV-2 Yuan M, Liu HJ, Wu NC, Lee CCD, Zhu XY, Zhao FZ, Huang DL, Yu WL, Hua YZ, Tien H, Rogers TF, Landais E, Sok D, Jardine JG, Burton DR, Wilson IA Science, 369(6507), 1119, 2020 |
| 6 |
Commonality despite exceptional diversity in the baseline human antibody repertoire Briney B, Inderbitzin A, Joyce C, Burton DR Nature, 566(7744), 393, 2019 |
| 7 |
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses Steichen JM, Lin YC, Havenar-Daughton C, Pecetta S, Ozorowski G, Willis JR, Toy L, Sok D, Liguori A, Kratochvil S, Torres JL, Kalyuzhniy O, Melzi E, Kulp DW, Raemisch S, Hu XZ, Bernard SM, Georgeson E, Phelps N, Adachi Y, Kubitz M, Landais E, Umotoy J, Robinson A, Briney B, Wilson IA, Burton DR, Ward AB, Crotty S, Batista FD, Schief WR Science, 366(6470), 1216, 2019 |
| 8 |
Unprecedented Role of Hybrid N-Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies Shivatare VS, Shivatare SS, Lee CCD, Liang CH, Liao KS, Cheng YY, Saidachary G, Wu CY, Lin NH, Kwong PD, Burton DR, Wu CY, Wong CH Journal of the American Chemical Society, 140(15), 5202, 2018 |
| 9 |
Taking down defenses to improve vaccines Teijaro JR, Burton DR Science, 359(6373), 277, 2018 |
| 10 |
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows Sok D, Le KM, Vadnais ML, Saye-Francisco KL, Jardine JG, Torres JL, Berndsen ZT, Kong L, Tanfield RS, Ruiz J, Ramos A, Liang CH, Chen PL, Criscitiello MF, Mwangi W, Wilson IA, Ward AB, Smider VV, Burton DR Nature, 548(7665), 108, 2017 |